FDA Inspection
Beth Israel Deaconess Medical CenterBeth Israel Deaconess Medical Center – FDA Inspection, Oct 26, 2010
Record Details
This FDA Inspection record concerns Beth Israel Deaconess Medical Center, with an inspection on October 26, 2010, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- October 26, 2010
- Product Type
- Biologics
View Company Profile
ID · 54149587-bb77-4928-aa98-d88d7394a859
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 696010
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 606.65(e)Following manufacturer"s instructions
- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Beth Israel Deaconess Medical Center
7| Date | Classification | Office | Project area |
|---|---|---|---|
| April 30, 2025 | Not classified | New England District Office | |
| September 11, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 10, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 19, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 13, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Beth Israel Deaconess Medical Center
- FDA Inspection 1270644 - 2025-04-30
- FDA Inspection 1218205 - 2023-09-11
- FDA Inspection 1095042 - 2019-06-10
- FDA Inspection 1009640 - 2017-04-19
- FDA Inspection 914552 - 2015-02-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.